儿童急性红白血病富集NUP98融合且纯红亚型预后差
该研究分析了儿童肿瘤协作组AAML0531和AAML1031试验中经中心病理复核的24例(1.2%)儿童急性红白血病(AEL),评估形态学、免疫表型、细胞遗传学、分子及临床数据。结果显示NUP98融合在AEL中高度富集(7/22,31.8%),且纯红白血病(PEL)亚型总生存和无事件生存均显著差于红/髓亚型。
要点
- 儿童AEL中NUP98融合发生率31.8%,显著高于其他AML亚型的6.7%。
- 纯红白血病(PEL)5例中3例有NUP98融合,4例有复杂核型。
- PEL亚型5年总生存和无事件生存均显著劣于红/髓亚型。
核心结论
- AEL在儿童中罕见但遗传异质性强,NUP98融合富集,纯红亚型预后尤其不良。
研究设计与样本
- 回顾性分析儿童肿瘤协作组AAML0531和AAML1031试验中经中心病理复核的24例(1.2%)儿童AEL病例。
主要发现
- 24例中5例为纯红表型,19例为红/髓表型。
- 22例有分子数据者中7例(31.8%)存在NUP98融合,其他AML亚型为6.7%。
- 5例PEL中3例有NUP98融合,4例有复杂核型。
- 红/髓白血病按2017年WHO分类:MDS伴过多原始细胞-1(n=3)、MDS伴过多原始细胞-2(n=7)、非红系AML(n=5)、未知MDS/AML(n=4)。
- 14例中5例有WT1突变,均为红/髓白血病。
临床怎么用
- 儿童AEL应进行NUP98融合等分子检测以协助分型和预后判断。
- 纯红白血病亚型预后极差,需考虑强化治疗或临床试验。
局限性
- 样本量小(24例),部分病例分子数据缺失。
- 回顾性分析,来自特定临床试验人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute erythroid leukemia (AEL) is a rare subtype of acute myeloid leukemia (AML) primarily affecting older adults and was previously classified into erythroid/myeloid and pure erythroid subtypes. In this pediatric AEL study, we evaluated morphologic, immunophenotypic, cytogenetic, molecular, and clinical data of 24 (1.2%) cases from all cases undergoing central pathology review in Children's Oncology Group trials AAML0531 and AAML1031. Of 24 cases, 5 had a pure erythroid phenotype, and 19 had an erythroid/myeloid phenotype. NUP98 fusions were highly enriched in patients with AEL, occurring in 7 of 22 cases for which molecular data were available (31.8% vs 6.7% in other AML subtypes). Of 5 cases of pure erythroid leukemias (PELs), 3 had NUP98 fusions, and 4 had complex karyotypes. Erythroid/myeloid leukemias were reclassified by using the 2017 World Health Organization hematopathology classification as: myelodysplastic syndrome (MDS) with excess blasts-1 (n = 3), MDS with excess blasts-2 (n = 7), AML (nonerythroid, n = 5), and unknown MDS/AML (n = 4); the 5 cases of nonerythroid AML included 1 with an NUP98-NSD1 fusion, 2 with myelodysplasia-related changes, and 1 with a complex karyotype. Three cases of MDS with excess blasts-2 also had NUP98 rearrangements. WT1 mutations were present in 5 of 14 cases, all erythroid/myeloid leukemia. Outcomes assessment revealed statistically poorer overall survival (5-year, 20% ± 36% vs 66% ± 23%; P = .004) and event-free survival (5-year, 20% ± 36% vs 46% ± 23%; P = .019) for those with PEL than those with erythroid/myeloid leukemia. Our study supports that AEL is a morphologically and genetically heterogeneous entity that is enriched in NUP98 fusions, with the pure erythroid subtype associated with particularly adverse outcomes.
引用
- Chisholm KM, Heerema-McKenney AE, Choi JK, et al. Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group. Blood Adv. 2020. PMID: 33284945. doi:10.1182/bloodadvances.2020002712
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。